Nutrition challenges of cancer cachexia

• Published in: JPEN. Journal of parenteral and enteral nutrition Vol. 45; no. S2; p. 16
• Main Authors: Gaafer, Omnia U, Zimmers, Teresa A
• Format: Journal Article
• Language: English
• Published: United States 01.11.2021
• Subjects: Cachexia - etiology; Cachexia - therapy; Humans; Neoplasms - complications; Neoplasms - metabolism; Nutritional Status; Quality of Life; Weight Loss; malnutrition; animal models; nutrition; anorexia; cachexia; appetite; cancer
• ISSN: 1941-2444
• DOI: 10.1002/jpen.2287

Cancer cachexia, or progressive weight loss, often despite adequate nutrition contributes greatly to cancer morbidity and mortality. Cachexia is metabolically distinct from starvation or protein malnutrition, although many patients with cancer and cachexia exhibit lowered appetite and food consumption. Tumors affect neural mechanisms that regulate appetite and energy expenditure, while promoting wasting of peripheral tissues via catabolism of cardiac and skeletal muscle, adipose, and bone. These multimodal actions of tumors on the host suggest a need for multimodal interventions. However, multiple recent consensus guidelines for management of cancer cachexia differ in treatment recommendations, highlighting the lack of effective, available therapies. Challenges to defining appropriate nutrition or other interventions for cancer cachexia include lack of consensus on definitions, low strength of evidence from clinical trials, and a scarcity of robust, rigorous, and mechanistic studies. However, efforts to diagnose, stage, and monitor cachexia are increasing along with clinical trial activity. Furthermore, preclinical models for cancer cachexia are growing more sophisticated, encompassing a greater number of tumor types in organ-appropriate contexts and for metastatic disease to model the clinical condition more accurately. It is expected that continued growth, investment, and coordination of research in this topic will ultimately yield robust biomarkers, clinically useful classification and staging algorithms, targetable pathways, pivotal clinical trials, and ultimately, cures. Here, we provide an overview of the clinical and scientific knowledge and its limitations around cancer cachexia.